@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HC985P3V-V dc:established "1966-01-01"^^xsd:date ; skos:hiddenLabel "Guanethidine Sulfate"@en, "Isobarin"@en, "Ismelin"@en, "Guanethidine Sulfate (2:1)"@en, "Guanethidine Monosulfate"@en, "Guanethidine Sulfate (1:1)"@en, "Sulfate de guanéthidine"@fr, "Guanethidine Sulfate (2:1), 14C-Labeled"@en, "Guanethidine Sulfate (1:2)"@en ; mesh:allowableQualifier jvr:-THHNVC7V-3, jvr:-Q3979798-W, jvr:-R3QWLHRG-V, jvr:-NKM836P1-M, jvr:-HQRFT0C6-B, jvr:-S0CS1X5R-5, jvr:-G4R176S9-J, jvr:-XV06LPML-W, jvr:-W6SQV79N-S, jvr:-D0F21513-5, jvr:-NB0XHT3S-N, jvr:-G30ZJ446-J, jvr:-T9HQD7ST-J, jvr:-TJHVZCRZ-0, jvr:-CB30NGKB-3, jvr:-WK5F724J-1, jvr:-SBNWSM1T-R, jvr:-R0ZCQ8X6-J, jvr:-FWD2BGQ0-9, jvr:-L6C0XPHT-4, jvr:-BT300B3G-Q, jvr:-NHL3D2X0-S, jvr:-NFTHND7Q-8, jvr:-H7K65Q8S-Z, jvr:-M63HSDM7-1 ; skos:altLabel "5UBY8Y002G"@fr, "5UBY8Y002G"@en, "14920-15-1 (sulfate (1:2))"@fr, "14920-15-1 (sulfate (1:2))"@en, "645-43-2 (sulfate (1:1))"@fr, "645-43-2 (sulfate (1:1))"@en, "Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-"@fr, "Guanidine, (2-(hexahydro-1(2H)-azocinyl)ethyl)-"@en, "Oktadin"@en, "((2-Hexahydro-1(2H)-azocinyl)ethyl)guanidine"@en, "ZTI6C33Q2Q"@fr, "ZTI6C33Q2Q"@en, "55-65-2 (Guanethidine)"@fr, "55-65-2 (Guanethidine)"@en, "8AQ60474G9"@fr, "8AQ60474G9"@en, "60-02-6 (sulfate (2:1))"@fr, "60-02-6 (sulfate (2:1))"@en, "Octadine"@en, "87862-38-2 (sulfate (2:1), 14C-labeled)"@fr, "87862-38-2 (sulfate (2:1), 14C-labeled)"@en ; skos:inScheme jvr: ; skos:broader jvr:-ZZBZ7FQS-2 ; a skos:Concept, mesh:Descriptor ; dc:modified "2013-07-08"^^xsd:date ; mesh:pharmacologicalAction jvr:-FG8LP9J8-Q, jvr:-JG5CGZN8-C, jvr:-JHRKFGLJ-J ; skos:definition "An antihypertensive agent that acts by inhibiting selectively transmission in post-ganglionic adrenergic nerves. It is believed to act mainly by preventing the release of norepinephrine at nerve endings and causes depletion of norepinephrine in peripheral sympathetic nerve terminals as well as in tissues."@en ; skos:prefLabel "Guanethidine"@en, "Guanéthidine"@fr ; owl:sameAs ; dc:created "1999-01-01"^^xsd:date . jvr:-JG5CGZN8-C skos:prefLabel "Agents adrénergiques"@fr, "Adrenergic Agents"@en ; a mesh:Descriptor, skos:Concept . jvr:-FG8LP9J8-Q skos:prefLabel "Antihypertensive Agents"@en, "Antihypertenseurs"@fr ; a mesh:Descriptor, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-ZZBZ7FQS-2 skos:prefLabel "Guanidines"@fr, "Guanidines"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-HC985P3V-V . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-THHNVC7V-3 skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-R0ZCQ8X6-J skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-M63HSDM7-1 skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G4R176S9-J skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-R3QWLHRG-V skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T9HQD7ST-J skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-JHRKFGLJ-J skos:prefLabel "Sympatholytiques"@fr, "Sympatholytics"@en ; a mesh:Descriptor, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WK5F724J-1 skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .